Skip to content

HCA · NYSE

HCA Healthcare (HCA) Stock Price & Fundamentals

$736.67−1.43%−$10.65End-of-day price as of Oct 9, 2026

HCA Healthcare (HCA) closed at $736.67 on Oct 9, 2026, down 1.43% from the previous close of $747.32.

Share price, past year

1Y +43.01%

52-week range $512.26 – $747.97. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$736.67
Sep 30, 2026$725.30
Aug 31, 2026$690.93
Jul 31, 2026$664.36
Jun 30, 2026$649.36
May 29, 2026$652.67
Apr 30, 2026$608.72
Mar 31, 2026$586.59
Feb 27, 2026$564.49
Jan 30, 2026$585.05
Dec 31, 2025$580.72
Nov 28, 2025$562.00
Oct 31, 2025$514.41

Key statistics

Market cap
$163.93B
P/E (TTM)
25.4
EPS (TTM)
$29.03
Revenue (TTM)
$76.39B
Net income (TTM)
$6.79B
Shares outstanding
222.5M
Dividend yield
0.40%
52-week range
$512.26 – $747.97

HCA Healthcare's market cap is $163.93B, based on a share price of $736.67 and 222.5M shares outstanding as of Mar 31, 2026.

Financials

HCA Healthcare reported revenue of $75.60B for fiscal 2025, up 7.08% from fiscal 2024.

HCA Healthcare earned net income of $6.78B in fiscal 2025, a net margin of 9.0%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
HCA Healthcare annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$75.60B+7.1%$6.78B9.0%$28.33$7.69B
FY2024ended Dec 31, 2024$70.60B+8.7%$5.76B8.2%$22.00$5.64B
FY2023ended Dec 31, 2023$64.97B+7.9%$5.24B8.1%$18.97$4.69B
FY2022ended Dec 31, 2022$60.23B+2.5%$5.64B9.4%$19.15$4.13B
FY2021ended Dec 31, 2021$58.75B+14.0%$6.96B11.8%$21.16$5.38B
FY2020ended Dec 31, 2020$51.53B+0.4%$3.75B7.3%$10.93$6.40B
FY2019ended Dec 31, 2019$51.34B+10.0%$3.51B6.8%$10.07$3.44B
FY2018ended Dec 31, 2018$46.68B+7.0%$3.79B8.1%$10.66$3.19B
FY2017ended Dec 31, 2017$43.61B+5.1%$2.22B5.1%$5.95$2.41B
FY2016ended Dec 31, 2016$41.49B—$2.89B7.0%$7.30$2.89B
HCA Healthcare quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q1 FY2026ended Mar 31, 2026$19.11B$1.62B$7.15
Q4 FY2025ended Dec 31, 2025$19.51B$1.88B$8.09
Q3 FY2025ended Sep 30, 2025$19.16B$1.64B$6.96
Q2 FY2025ended Jun 30, 2025$18.61B$1.65B$6.83
Q1 FY2025ended Mar 31, 2025$18.32B$1.61B$6.45
Q4 FY2024ended Dec 31, 2024$18.29B$1.44B$5.66
Q3 FY2024ended Sep 30, 2024$17.49B$1.27B$4.88
Q2 FY2024ended Jun 30, 2024$17.49B$1.46B$5.53

Company profile

Name
HCA Healthcare, Inc.
Ticker
HCA
Exchange
NYSE
Industry (SEC SIC)
Services-General Medical & Surgical Hospitals, NEC
Headquarters
One Park Plz, Nashville, TN 37203
Fiscal year ends
December
SEC CIK
0000860730

Recent SEC filings

Frequently asked questions

What is HCA Healthcare's stock price?

HCA Healthcare (HCA) closed at $736.67 on Oct 9, 2026, down 1.43% from the previous close of $747.32.

What is HCA Healthcare's market cap?

HCA Healthcare's market cap is $163.93B, based on a share price of $736.67 and 222.5M shares outstanding as of Mar 31, 2026.

How much revenue does HCA Healthcare make?

HCA Healthcare reported revenue of $75.60B for fiscal 2025, up 7.08% from fiscal 2024.

What is HCA's P/E ratio?

HCA Healthcare's price-to-earnings ratio is 25.4, based on trailing twelve-month diluted EPS of $29.03.

Does HCA Healthcare pay a dividend?

Yes. HCA Healthcare declared $2.94 per share in dividends over the last four quarters, a yield of 0.40%.

Sources and methodology

Fundamentals come from HCA Healthcare, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures